Mirae Asset Global Investments Co., Ltd. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$660,000
-53.0%
901,835
-26.8%
0.00%
-50.0%
Q2 2022$1,405,000
-72.5%
1,232,456
-50.5%
0.00%
-20.0%
Q1 2022$5,106,000
+29.6%
2,490,482
+82.0%
0.01%
-37.5%
Q4 2021$3,941,000
-31.4%
1,368,439
+1.1%
0.01%
-46.7%
Q3 2021$5,741,000
-33.8%
1,353,929
-17.4%
0.02%
-37.5%
Q2 2021$8,667,000
+534.5%
1,638,400
+457.6%
0.02%
+380.0%
Q1 2021$1,366,000
-36.3%
293,841
-54.8%
0.01%
-37.5%
Q4 2020$2,145,000
+59.1%
649,881
+59.6%
0.01%
+14.3%
Q3 2020$1,348,000
+13.4%
407,258
+15.4%
0.01%0.0%
Q2 2020$1,189,000
-1.1%
352,792
+12.4%
0.01%
-22.2%
Q1 2020$1,202,000
-34.3%
313,827
+3.6%
0.01%
-18.2%
Q4 2019$1,829,000
-55.6%
302,795
-44.4%
0.01%
-62.1%
Q3 2019$4,116,000
-24.9%
544,408
+34.6%
0.03%
-23.7%
Q2 2019$5,482,000
+21.3%
404,560
+12.0%
0.04%
-37.7%
Q4 2017$4,520,000
+59.7%
361,062
+6.6%
0.06%
+17.3%
Q3 2017$2,830,000
-45.0%
338,552
+11.7%
0.05%
-41.6%
Q2 2017$5,144,000303,1100.09%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Beryl Capital Management LLC 4,898,927$6,246,1320.70%
Yakira Capital Management, Inc. 620,019$790,5240.22%
Crystalline Management Inc. 230,817$294,2920.21%
DELTEC ASSET MANAGEMENT LLC 475,000$605,6250.14%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 2,283,979$2,912,0730.12%
PenderFund Capital Management Ltd. 123,444$2130.06%
FIFTH LANE CAPITAL, LP 100,000$127,0000.04%
CSS LLC/IL 476,831$607,9600.04%
Penserra Capital Management LLC 220,858$2800.01%
King Wealth Management Group 16,000$200.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders